Weisler, Richard H <br/><br/>
Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD.  [electronic resource] 

 -  Clinical pharmacology in drug development  02 2018 
 - 160-167 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2160-7648 
<br/><br/><label>Standard No.: </label>10.1002/cpdd.361  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Area Under Curve<br/>Attention Deficit Disorder with Hyperactivity--drug therapy<br/>Biological Availability<br/>Central Nervous System Stimulants--adverse effects<br/>Cross-Over Studies<br/>Delayed-Action Preparations--adverse effects<br/>Dietary Fats--pharmacology<br/>Fasting--metabolism<br/>Female<br/>Food-Drug Interactions<br/>Healthy Volunteers<br/>Humans<br/>Male<br/>Methylphenidate--adverse effects<br/>Tablets<br/>Therapeutic Equivalency<br/>Young Adult